New cancer clinical trial: Study to Evaluate CCS1477 in Advanced Tumours

Published on: June 25, 2018 at 12:00PM
Conditions:   Metastatic Castration-Resistant Prostate Cancer;   Advanced Solid Tumors
Interventions:   Drug: CCS1477;   Drug: Abiraterone acetate;   Drug: Enzalutamide
Sponsor:   CellCentric Ltd.
Not yet recruiting
https://ift.tt/2Mr1eRB